Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated
Public ClinicalTrials.gov record NCT06613685. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Operationally Seamless Phase 2/3, Randomized, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of GS-1720 in Combination With GS-4182 Versus Biktarvy in Treatment-Naive People With HIV-1
Study identification
- NCT ID
- NCT06613685
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 73 participants
Conditions and interventions
Conditions
Interventions
- Bictegravir/emtricitabine/tenofovir alafenamide Drug
- Placebo to Match BVY Drug
- Placebo to Match GS1720/GS-4182 FDC Drug
- lenacapavir pacfosacil Drug
- lepetegravir Drug
- lepetegravir/lenacapavir pacfosacil FDC Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 20, 2024
- Primary completion
- Mar 15, 2026
- Completion
- Mar 15, 2026
- Last update posted
- Apr 14, 2026
2024 – 2026
United States locations
- U.S. sites
- 21
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB 1917 Research Clinic | Birmingham | Alabama | 35222 | — |
| The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Torrance | California | 90502 | — |
| Mills Clinical Research | West Hollywood | California | 90046 | — |
| Georgetown University Medical School | Washington D.C. | District of Columbia | 20007 | — |
| Midland Florida Clinical Research Center, LLC | DeLand | Florida | 32720 | — |
| Midway Immunology and Research Center | Ft. Pierce | Florida | 34982 | — |
| Floridian Clinical Research, LLC | Miami Lakes | Florida | 33016 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| Triple O Research Institute, P.A. | West Palm Beach | Florida | 33407 | — |
| Emory University Hospital Midtown Infectious Disease Clinic | Atlanta | Georgia | 30308 | — |
| Mercer University, Department of Internal Medicine | Macon | Georgia | 31201 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| Saint Michael's Medical Center | Newark | New Jersey | 07102 | — |
| NYU Langone Health Vaccine Center | New York | New York | 10016 | — |
| Medical University of South Carolina (MUSC) Research Nexus | Charleston | South Carolina | 29425 | — |
| St Hope Foundation, Inc. | Bellaire | Texas | 77401 | — |
| Prism Health North Texas, Aids Arms | Dallas | Texas | 75208 | — |
| North Texas Infectious Diseases Consultants, PA | Dallas | Texas | 75246 | — |
| Texas Centers for Infectious Disease Associates | Fort Worth | Texas | 76104 | — |
| UT Health San Antonio | San Antonio | Texas | 78229 | — |
| MultiCare Rockwood Main Clinic | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06613685, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06613685 live on ClinicalTrials.gov.